Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Van Den Heuvel R et al. | 2001 | intact cell/cell culture, 3T3 cells (mouse fibroblasts) and mouse bone marrow cells | magnetic field, 50/60 Hz | 80 µT |
Tao Q et al. | 1999 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Phillips JL et al. | 1986 | intact cell/cell culture, human colon carcinoma cell line (Colo 205 and Colo 320 DM) | electric field, magnetic field, 50/60 Hz | 100 µT |
Cain CD et al. | 1993 | intact cell/cell culture, C3H 10T1/2 and UV/TDT10e (10e) cells (mouse fibroblast cells) | magnetic field, 50/60 Hz, co-exposure | 0.1 mT |
Zhao YL et al. | 1999 | intact cell/cell culture, INITC3H 10T1/2 cells (derived from mouse embryo fibroblasts, transformed carcinogenically by methylcholanthrene, resulting neoplastic phenotype can be suppressed by the presence of retinyl acetate) | magnetic field, 50/60 Hz | 100 µT |
Fedrowitz M et al. | 2002 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz, source not given | 100 µT |
Schimmelpfeng J et al. | 2005 | intact cell/cell culture, PC-12 cells/rat | magnetic field, 50/60 Hz | 100 µT |
Trillo MA et al. | 2012 | intact cell/cell culture, Hep G2 cells (hepatic transformed cell line) and NB69 cells (neuroblastoma cells) | magnetic field, low frequency, 50/60 Hz, co-exposure | 100 µT |
Martinez MA et al. | 2012 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | magnetic field, low frequency, 50/60 Hz | 100 µT |
Luukkonen J et al. | 2014 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.